Tumor-Associated Macrophages Recruit CCR6+ Regulatory T Cells and Promote the Development of Colorectal Cancer via Enhancing CCL20 Production in Mice

Background Tumor-associated macrophages (TAMs) remodel the colorectal cancer (CRC) microenvironment. Yet, findings on the role of TAMs in CRC seem to be contradictory compared with other cancers. FoxP3+ regulatory T (Treg)-cells dominantly infiltrate CRC. However, the underlying molecular mechanism in which TAMs may contribute to the trafficking of Treg-cells to the tumor mass remains unknown. Methodology/Principal Findings CRC was either induced by N-methyl-N-nitrosourea (MNU) and H. pylori or established by subcutaneous injection of mouse colorectal tumor cell line (CMT93) in mice. CMT93 cells were co-cultured with primary macrophages in a transwell apparatus. Recruitment of FoxP3 green fluorescence protein positive (FoxP3GFP+) Treg-cells was assessed using the IVIS Imaging System or immunofluorescence staining. A role for macrophages in trafficking of Treg-cells and in the development of CRC was investigated in CD11b diphtheria toxin receptor (CD11b-DTR) transgenic C57BL/6J mice in which macrophages can be selectively depleted. Treg-cells remarkably infiltrated solid tumor, and predominantly expressed the homing chemokine receptor (CCR) 6 in the induced CRC model. Both CMT93 cancer cells and macrophages produced a large amount of CCL20, the sole ligand of CCR6 in vitro and in vivo. Injection of recombinant mouse CCL20 into tumor sites promoted its development with a marked recruitment of Treg-cells in the graft CRC model. Conditional macrophage ablation decreased CCL20 levels, blocked Treg-cell recruitment and inhibited tumor growth in CD11b-DTR mice grafted with CMT93. Conclusions/Significance TAMs recruit CCR6+ Treg-cells to tumor mass and promote its development via enhancing the production of CCL20 in a CRC mouse model.

• Publication year

  2011

• Venue

  PLoS ONE

• Publication date

  2011-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.pone.0019495PMID 21559338PMCID 3084880
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibody-mediated FOXP3 protein therapy induces apoptosis in cancer cells in vitro and inhibits metastasis in vivo.

  2009cited by this paper
• Dynamic Behavior and Function of Foxp3+ Regulatory T Cells in Tumor Bearing Host

  2009influential reference
• Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation.

  2009cited by this paper
• Key role of macrophages in the pathogenesis of CD18 hypomorphic murine model of psoriasis.

  2009cited by this paper
• CCR6 is required for IL-23-induced psoriasis-like inflammation in mice.

  2009cited by this paper
• Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.

  2009cited by this paper
• Regulatory T cells and immune tolerance.

  2008cited by this paper
• Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner

  2008cited by this paper
• Mouse models for the study of colon carcinogenesis.

  2008cited by this paper
• Dynamics of neutrophil infiltration during cutaneous wound healing and infection using fluorescence imaging.

  2008cited by this paper
• Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma

  2007cited by this paper
• FOXP3 modifies the phenotypic and functional properties of regulatory T cells

  2007cited by this paper
• Plasmin Triggers Cytokine Induction in Human Monocyte-Derived Macrophages

  2007cited by this paper
• Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens

  2007cited by this paper
• Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients.

  2007cited by this paper
• Monocyte/Macrophage Suppression in CD11b Diphtheria Toxin Receptor Transgenic Mice Differentially Affects Atherogenesis and Established Plaques

  2007cited by this paper
• High Macrophage Infiltration along the Tumor Front Correlates with Improved Survival in Colon Cancer

  2007cited by this paper
• Natural Regulatory T Cells and De Novo-Induced Regulatory T Cells Contribute Independently to Tumor-Specific Tolerance1

  2007cited by this paper
• Dynamics of the immune reaction to pancreatic cancer from inception to invasion.

  2007cited by this paper
• In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer

  2006cited by this paper
• Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

  2006cited by this paper
• Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent.

  2006cited by this paper
• Cholesterol-induced Apoptotic Macrophages Elicit an Inflammatory Response in Phagocytes, Which Is Partially Attenuated by the Mer Receptor*

  2006cited by this paper
• CD4+CD25+FOXP3+ Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer

  2006cited by this paper
• Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer.

  2006influential reference
• Regulatory T cells, tumour immunity and immunotherapy

  2006influential reference
• Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

  2006cited by this paper
• FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma

  2005cited by this paper
• CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset.

  2005cited by this paper
• Homing to suppress: address codes for Treg migration.

  2005cited by this paper
• Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells

  2005cited by this paper
• Intestinal macrophages: unique effector cells of the innate immune system

  2005cited by this paper
• Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.

  2005cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004influential reference
• Developmental Stage, Phenotype, and Migration Distinguish Naive- and Effector/Memory-like CD4+ Regulatory T Cells

  2004cited by this paper
• Tumour-educated macrophages promote tumour progression and metastasis

  2004cited by this paper
• Chemokines in Lymphocyte Trafficking and Intestinal Immunity

  2003cited by this paper
• Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.

  2003cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma

  2003cited by this paper
• CD25+ regulatory T cells and tumor immunity.

  2003cited by this paper
• Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer.

  2003cited by this paper
• Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer.

  2002cited by this paper
• Do CD4+ CD25+ immunoregulatory T cells hinder tumor immunotherapy?

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy

  2001cited by this paper
• Topoisomerase I Inhibitors with an Indolocarbazole Structure Transporter as a Transporter of NB-506 and J-107088 , Resistance / Placenta-Specific , ATP-binding Cassette Identification of Breast Cancer Resistant Protein / Mitoxantrone Updated

  2001cited by this paper
• Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses

  2001cited by this paper
• Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

  1999cited by this paper
• CC-Chemokine Receptor 6 Is Expressed on Diverse Memory Subsets of T Cells and Determines Responsiveness to Macrophage Inflammatory Protein 3α

  1999cited by this paper
• Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

  1999cited by this paper
• CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha.

  1999cited by this paper
• Cloning and characterization of exodus, a novel beta-chemokine.

  1997cited by this paper
• Cloning and Characterization of Exodus, a Novel β-Chemokine

  1997cited by this paper
• Molecular Cloning of a Novel Human CC Chemokine EBI1-ligand Chemokine That Is a Specific Functional Ligand for EBI1, CCR7*

  1997cited by this paper
• Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.

  1996cited by this paper
• [Inflammation and cancer].

  1974cited by this paper
• Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats.

  1974influential reference

• A Folate Receptor β-Targeted TLR7 Agonist Significantly Augments Checkpoint Inhibitor Potencies by Reprogramming Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells.

  2026cites this paper
• CCL20-CCR6 signaling in tumor microenvironment: Functional roles, mechanisms, and immunotherapy targeting.

  2025cites this paper
• Targetable axes of tumor-associated macrophages: An MSF framework for precision immunotherapy.

  2025cites this paper
• Radioresistance Mechanisms in Head and Neck Cancer

  2025cites this paper
• Regulatory T cells in the tumour microenvironment

  2025cites this paper
• Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs

  2025cites this paper
• Tumor-associated macrophages in colon cancer immunotherapy: mechanisms, natural product interventions, and microenvironment remodeling

  2025cites this paper
• The Role of Tumor Microenvironment and Immune Cell Crosstalk in Triple-Negative Breast Cancer (TNBC): Emerging Therapeutic Opportunities.

  2025cites this paper
• CCR9 shapes the immune microenvironment of colorectal cancer modulating the balance between intratumoral CD8+ T cell and FoxP3+ Helios+ Treg subpopulations

  2025cites this paper
• Transforming cancer immunotherapy: Overcoming immunosuppression in tumors via gene silencing techniques based on nanoparticles

  2025cites this paper
• The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy

  2025cites this paper
• Targeted and personalized immunotherapy in lung adenocarcinoma: single-cell RNA sequencing of MAFF+ tumor cells and the therapeutic potential of FOS

  2025cites this paper
• Fighting cancer smarter: Using hydrogel delivery systems to target chemokines.

  2025cites this paper
• Longitudinal and multimodal auditing of tumor adaptation to CDK4/6 inhibitors in HR+ metastatic breast cancers

  2025cites this paper
• Immunologic tumor microenvironment modulators for turning cold tumors hot

  2024cites this paper
• Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy

  2024cites this paper
• RANKL/RANK signaling recruits Tregs via the CCL20–CCR6 pathway and promotes stemness and metastasis in colorectal cancer

  2024cites this paper
• Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives

  2024cites this paper
• Targeting tumor-associated macrophages with nanocarrier-based treatment for breast cancer: A step toward developing innovative anti-cancer therapeutics

  2024cites this paper
• Cold and hot tumors: from molecular mechanisms to targeted therapy

  2024cites this paper
• Human milk feeding practices and serum immune profiles of one-year-old infants in the CHILD birth cohort study

  2024cites this paper
• Tumor‐associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire

  2024cites this paper
• Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies

  2024cites this paper
• A review concerning the breast cancer-related tumour microenvironment.

  2024cites this paper
• Rationale for immune checkpoint inhibitors plus targeted therapy for advanced renal cell carcinoma

  2024cites this paper
• Preadipocytes potentiate melanoma progression and M2 macrophage polarization in the tumor microenvironment.

  2024cites this paper
• CMTM7 shapes the chronic inflammatory and immunosuppressive tumor microenvironment in hepatocellular carcinoma as an M2 macrophage biomarker

  2024cites this paper
• Myeloid cells meet CD8+ T cell exhaustion in cancer: What, why and how.

  2024cites this paper
• Mouse Models to Evaluate the Functional Role of the Tumor Microenvironment in Cancer Progression and Therapy Responses.

  2024cites this paper
• Predictive and Prognostic Relevance of Tumor-Infiltrating Immune Cells: Tailoring Personalized Treatments against Different Cancer Types

  2024cites this paper
• Expanded Alternatives of CRISPR–Cas9 Applications in Immunotherapy of Colorectal Cancer

  2023cites this paper
• Metabolic interplay: tumor macrophages and regulatory T cells.

  2023cites this paper
• The PTEN-associated immune prognostic signature reveals the landscape of the tumor microenvironment in glioblastoma.

  2023cites this paper
• Interaction of tumor-associated macrophages with stromal and immune components in solid tumors: Research progress (Review)

  2023cites this paper
• Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy.

  2023cites this paper
• Research progress on the role of tumor-associated macrophages in tumor development and their use as molecular targets (Review)

  2023cites this paper
• The role of tumor-associated macrophages in the progression, prognosis and treatment of endometrial cancer

  2023cites this paper
• Macrophages as Promising Carriers for Nanoparticle Delivery in Anticancer Therapy

  2023cites this paper
• Establishment and Characterization of Free-Floating 3D Macrophage Programming Model in the Presence of Cancer Cell Spheroids

  2023influential citation
• Microbiota as the unifying factor behind the hallmarks of cancer

  2023cites this paper
• Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers

  2023cites this paper
• Cellular and Molecular Mechanisms of the Tumor Stroma in Colorectal Cancer: Insights into Disease Progression and Therapeutic Targets

  2023cites this paper
• PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway

  2023cites this paper
• The Good and the Bad: Monocytes’ and Macrophages’ Diverse Functions in Inflammation

  2022cites this paper
• Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy

  2022cites this paper
• Induced CAR-Macrophages as a Novel Therapeutic Cell Type for Cancer Immune Cell Therapies

  2022cites this paper
• Hyperprogression, a challenge of PD-1/PD-L1 inhibitors treatments: potential mechanisms and coping strategies.

  2022cites this paper
• The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial Cancer

  2022cites this paper
• The Give-and-Take Interaction Between the Tumor Microenvironment and Immune Cells Regulating Tumor Progression and Repression

  2022cites this paper
• Nanoparticle mediated targeting of toll-like receptors to treat colorectal cancer.

  2022cites this paper
• Role of Chemokines in Colorectal Cancer

  2022cites this paper
• Forkhead box M1 recruits FoxP3+ Treg cells to induce immune escape in hilar cholangiocarcinoma

  2022cites this paper
• Microbiota Dysbiosis a Cause of Colorectal Cancer or Not? A Systematic Review

  2022cites this paper
• Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers

  2022cites this paper
• TAM-targeted reeducation for enhanced cancer immunotherapy: Mechanism and recent progress

  2022cites this paper
• Metabolic guidance and stress in tumors modulate antigen-presenting cells

  2022cites this paper
• Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer

  2022cites this paper
• How the Tumor Micromilieu Modulates the Recruitment and Activation of Colorectal Cancer-Infiltrating Lymphocytes

  2022cites this paper
• PA-MSHA induces inflamed tumor microenvironment and sensitizes tumor to anti-PD-1 therapy

  2022cites this paper
• Therapeutic targeting of regulatory T cells in cancer.

  2022cites this paper
• Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting

  2022cites this paper
• Igniting Hope for Tumor Immunotherapy: Promoting the “Hot and Cold” Tumor Transition

  2022cites this paper
• Multifaceted roles of CCL20 (C-C motif chemokine ligand 20): mechanisms and communication networks in breast cancer progression

  2021cites this paper
• Advance of nano anticancer therapies targeted on tumor-associated macrophages

  2021cites this paper
• Cellular Indoctrination: How the Tumor Microenvironment Reeducates Macrophages Towards Nefarious Ends

  2021cites this paper
• T‐Cell‐Derived Nanovesicles for Cancer Immunotherapy

  2021cites this paper
• Heterogeneous Myeloid Cells in Tumors

  2021cites this paper
• Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?

  2021cites this paper
• Tumor-Associated Macrophages: A Potential Target for Cancer Therapy

  2021cites this paper
• Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis

  2021cites this paper
• Tumor-Infiltrating Cytotoxic T Cells and Tumor-Associated Macrophages Correlate With the Outcomes of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

  2021influential citation
• Nanovesicle‐Mediated Targeted Delivery of Immune Checkpoint Blockades to Potentiate Therapeutic Efficacy and Prevent Side Effects

  2021cites this paper
• Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer

  2021cites this paper
• The prospects of Nanotherapeutic approaches for targeting Tumor-Associated Macrophages in oral cancer.

  2021cites this paper
• Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy

  2021cites this paper
• Targeting tumor-associated macrophages to synergize tumor immunotherapy

  2021cites this paper
• Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance

  2021cites this paper
• Macrophage polarization by phytotherapy in the tumor microenvironment

  2021cites this paper
• CCL20 induces colorectal cancer neoplastic epithelial cell proliferation, migration, and further CCL20 production through autocrine HGF-c-Met and MSP-MSPR signaling pathways

  2021cites this paper
• Macrophages in tumor: An inflammatory perspective.

  2021cites this paper
• Targeting Tumor-Associated Macrophages in Cancer Immunotherapy

  2021cites this paper
• Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End

  2021cites this paper
• Understanding and Targeting Human Cancer Regulatory T Cells to Improve Therapy.

  2021cites this paper
• Tumor-infiltrating T-regulatory cells adapt to altered metabolism to promote tumor-immune escape

  2021cites this paper
• Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer.

  2021cites this paper
• Relationship between Th17 immune response and cancer

  2021cites this paper
• Tongue Cancer Cell-Derived CCL20 Induced by Interaction With Macrophages Promotes CD163 Expression on Macrophages

  2021cites this paper
• Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site

  2020cites this paper
• The Role of Selected Chemokines and Their Receptors in the Development of Gliomas

  2020cites this paper
• High fucoxanthin wakame (Undaria pinnatifida) prevents tumor microenvironment formation in an AOM/DSS mouse carcinogenic model

  2020cites this paper
• Cancer Cells and M2 Macrophages: Cooperative Invasive Ecosystem Engineers

  2020cites this paper
• Correlations between CD4+FoxP3+ Treg and expression of FoxM1 and Ki‐67 in gastric cancer patients

  2020cites this paper
• Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma

  2020cites this paper
• CCL20 Signaling in the Tumor Microenvironment.

  2020cites this paper
• Targeting tumor-associated macrophages as an antitumor strategy.

  2020cites this paper
• Current Perspectives, Challenges and Advances in Cell Based Therapies

  2020cites this paper
• Tumor-Associated Macrophages in Tumor Immunity

  2020cites this paper
• Mechanisms of Immunosuppression in Colorectal Cancer

  2020cites this paper
• CCL18 in the Progression of Cancer

  2020cites this paper
• The Role of Chemokines in the Development of Gastric Cancer—Diagnostic and Therapeutic Implications

  2020cites this paper